Constance Blunt, MD

Medical oncologist, Mary Bird Perkins Cancer Center

Articles by Constance Blunt, MD

Potential Impact of Loss of Coverage for Health Care Screenings: Constance Blunt, MD

ByPearl Steinzor,Mary Caffrey,Constance Blunt, MD

June 10th 2025

Constance Blunt, MD, medical oncologist, Mary Bird Perkins Cancer Center, discusses the potential consequences of losing free health care screening coverage.

Mobile Services Improve Access to Preventive Care, Cancer Screening: Constance Blunt, MD

ByPearl Steinzor,Mary Caffrey,Constance Blunt, MD

June 4th 2025

Constance Blunt, MD, medical oncologist, Mary Bird Perkins Cancer Center, shares how one mobile health care initiative is addressing critical barriers to medical access for underserved populations.

Improving Cancer Detection, Screening Uptake in Community Oncology: Constance Blunt, MD

ByMary Caffrey,Pearl Steinzor,Constance Blunt, MD

May 15th 2025

Constance Blunt, MD, medical oncologist, Mary Bird Perkins Cancer Center, discusses some of the recent trends in cancer detection, screenings, and resource utilization in community oncology.

Constance Blunt, MD

Articles by Constance Blunt, MD

Potential Impact of Loss of Coverage for Health Care Screenings: Constance Blunt, MD

Mobile Services Improve Access to Preventive Care, Cancer Screening: Constance Blunt, MD

Improving Cancer Detection, Screening Uptake in Community Oncology: Constance Blunt, MD

Latest Updated Articles

Trending on AJMC

IEHP CEO Weighs in: Who Pays the Price When Millions Lose Medicaid Coverage?

FDA Approves Belantamab Mafodotin Combo for Relapsed or Refractory Multiple Myeloma

FDA Approves Elinzanetant, a Hormone-Free Option for Hot Flashes in Menopause

Eliminating Cost Sharing Boosted Follow-Up Colonoscopy Rates

Belantamab Mafodotin Can Help Fill Access Gaps in BCMA-Directed Myeloma Therapy: Hearn Jay Cho, MD, PhD